Name | vildagliptin |
---|---|
Synonyms |
(R)-1-[2-((5S,7S)-3-hydroxy-adamantan-1-ylamino)-acetyl]-pyrrolidine-2-carbonitrile
2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.1]dec-1-yl)amino]acetyl]-, (2R)- (2R)-Vildagliptin (2R)-1-[N-(3-Hydroxyadamantan-1-yl)glycyl]-2-pyrrolidinecarbonitrile |
Description | (2R)-Vildagliptin is the inactive isomer of Vildagliptin (HY-14291), and can be used as an experimental control. Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity[1]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 531.3±50.0 °C at 760 mmHg |
Molecular Formula | C17H25N3O2 |
Molecular Weight | 303.40 |
Flash Point | 275.1±30.1 °C |
Exact Mass | 303.194672 |
PSA | 76.36000 |
LogP | -0.14 |
Vapour Pressure | 0.0±3.2 mmHg at 25°C |
Index of Refraction | 1.601 |